Advances in the study of the role of MCP-1 in type 2 diabetes mellitus
孙丽华 1胡芳志2
扫码查看
点击上方二维码区域，可以放大扫码查看
作者信息
1. 济宁医学院临床医学院,济宁 272013
2. 济宁市第一人民医院内分泌与代谢科,济宁 272011
折叠
摘要
2 型糖尿病(T2DM)是一种常见的内分泌慢性代谢性疾病,其发病率逐年升高,呈现年轻化的趋势,且长期慢性高血糖易引起多种并发症,影响人类的生活质量,已成为严重危害人类生命健康的疾病,但对于其发病机制目前尚不明确.单核细胞趋化蛋白-1(monocyte chemotactic protein 1,MCP-1)作为CC趋化因子家族中的一员,参与多种自身免疫性疾病的发生发展.目前已有的研究结果显示,MCP-1 与T2DM并发症中的大血管、微血管病变及神经病变相关联,可能参与其发病机制.本文就MCP-1 在T2DM及其并发症中的研究进展作一论述.
Abstract
Type 2 diabetes mellitus(T2DM)is a common endocrine chronic metabolic disease,the incidence of which is increasing year by year,presenting a trend of rejuvenation,and long-term chronic hyperglycemia is prone to cause a variety of complications,which affects the quality of life of the patients,and it has become a disease that seriously jeopardizes the life and health of human beings,but the pathogenesis of the disease is still not clear.As a member of the CC chemokine family,monocyte chemotactic protein 1(MCP-1)is involved in the development of a variety of autoim-mune diseases,and the results of current studies have shown that MCP-1 is associated with macrovascular and microvas-cular lesions and neurological complications of T2DM,and may be involved in its pathogenesis.In this article,we discuss the research progress of MCP-1 in type 2 diabetes mellitus and its complications.
维普
万方数据